Leadership Team

Yong-Chul Kim
CEO/CTO

  • B.S-M.S-Ph.D. : Seoul Natl. Univ., Pharmacy
  • Post-Doc. : Natl. Inst. Health, USA
  • Professor in Lab. of Drug Discovery , GIST, Life Sciences
  • GIST AI- based Drug Development Center Director
  • ChemBridge, Inc. (San Diego, CA)

Soo Yeon Jang
CEO

  • B.S-M.S : Seoul Natl. Univ., Pharmacy
  • Natl. Inst. Health, USA Researcher
  • USP(United States of Pharmacopeia) Visiting Fellow
  • MFDS Researcher
  • Seoul Natl. Univ. Hospital Clinical Pharmacist

Yong-Chul Kim
CEO/CTO

  • B.S-M.S-Ph.D. : Seoul Natl. Univ., Pharmacy
  • Post-Doc. : Natl. Inst. Health, USA
  • Professor in Lab. of Drug Discovery , GIST, Life Sciences
  • GIST AI- based Drug Development Center Director
  • ChemBridge, Inc. (San Diego, CA)

Soo Yeon Jang
CEO

  • B.S-M.S : Seoul Natl. Univ., Pharmacy
  • Natl. Inst. Health, USA Researcher
  • USP(United States of Pharmacopeia) Visiting Fellow
  • MFDS Researcher
  • Seoul Natl. Univ. Hospital Clinical Pharmacist

Jong Hyeok Park
CFO

  • B.S-M.S : Seoul Natl. Univ., Material Science Engineering
  • KAIST, AMP
  • Carnegie Mellon Univ. MBA
  • Smilegate Investment Vice President
  • MVP Partners Director
  • Bain & Company Consultant
  • LG Electronics Technology Strategy CTO staff

Jong Hyeok Park
CFO

  • B.S-M.S : Seoul Natl. Univ., Material Science Engineering
  • KAIST, AMP
  • Carnegie Mellon Univ. MBA
  • Smilegate Investment Vice President
  • MVP Partners Director
  • Bain & Company Consultant
  • LG Electronics Technology Strategy CTO staff

Keon Wook Kang
CTO

  • B.S-M.S-Ph.D. : Seoul Natl. Univ., Pharmacy
  • Professor, Seoul Natl. Univ., Pharmacology
  • Professor in Chosun Univ. Pharmacy
  • University of California at Irvine Post-Doc
  • Seoul Natl. Univ. New Drug Development Research Center Post-Doc

Miran Moon
Executive Director, Global Clinical Development and Strategy

  • B.S-M.S : Ewha Womans Univ., Pharmacy
  • Celgene Korea, Country Lead of Clinical Operations
  • Otuska Pharmaceutical Ltd., Team Leader of Clinical Operations
  • AstraZeneca, CRM & Sr. CRA
  • Pfizer, Sr. CRA & CRA
 

Soo Jin Kim
Executive Director, Global innovative Drug Discovery & Development

  • B.S-M.S : SungKyunKwan univ.
  • Seoul Natl. Univ., Pharmacy
  • CKD pharmaceutical Corp., Team Leader of Preclinical Research department
  • Tiumbio., Director of Pharmacology

Miran Moon
Executive Director, Global Clinical Development and Strategy

  • B.S-M.S : Ewha Womans Univ., Pharmacy
  • Celgene Korea, Country Lead of Clinical Operations
  • Otuska Pharmaceutical Ltd., Team Leader of Clinical Operations
  • AstraZeneca, CRM & Sr. CRA
  • Pfizer, Sr. CRA & CRA

Myung Jin Kim
Executive Director, Global innovative Drug Discovery & Development

  • M.S-Ph.D. : Korea Univ., Biomedical Science
  • Pin Therapeutics Inc., Executive Director of Bioscience division
  • Handok Co., Ltd., Head of New Drug R&D department
  • Institut Pasteur Korea, Head of Functional Morphometry Team (Oncology)
  • Institut Pasteur Korea, Invited Scientist at the Institut Pasteur France